Imprivata, a prominent provider of access management solutions for healthcare and other critical sectors, has announced its acquisition of Verosint, a company specializing in Identity Threat Detection and Response (ITDR). This strategic move aims to modernize enterprise access management by integrating advanced, frictionless, and passwordless access capabilities across various user types, including frontline staff and third-party identities.
The acquisition enhances Imprivata’s objective to ensure efficient, secure, and compliant access across clinical and enterprise environments. The unified platform provided by Imprivata allows organizations to effectively manage both internal and external identities while mitigating threats and minimizing total ownership costs.
Fran Rosch, CEO of Imprivata, emphasized the importance of understanding risk in modern access management. “This acquisition allows us to deliver greater value to our customers at a faster pace,” Rosch stated. By incorporating Verosint’s AI-powered risk assessment engine into their offerings, Imprivata strengthens its vision of creating a comprehensive passwordless access ecosystem. The company has already rolled out the industry’s first passwordless, zero-trust solution designed specifically for shared device access, particularly for frontline workers.
Enhancing Security with AI-Driven Risk Detection
The integration of Verosint’s ITDR technology significantly bolsters Imprivata’s security framework. This technology continuously monitors for unusual user behaviors, validates workflow integrity, and automates responses to potential security threats. Key features of the combined platform include:
– AI-driven continuous risk assessment to proactively detect anomalies and prevent breaches
– Automated response mechanisms that can block, challenge, or escalate authentication when risks are identified
– Comprehensive identity intelligence that enhances access protection across the enterprise
These capabilities protect the identity infrastructures that healthcare teams rely on daily, ensuring that security measures adapt to emerging threats.
The acquisition also propels Imprivata’s commitment to a passwordless future at an enterprise scale. Upcoming initiatives include the integration of FIDO passkey and facial authentication technologies, which aim to enhance security while improving the user experience. Additional plans involve operational analytics that provide near real-time insights into access patterns and workflow optimization, as well as universal authentication support across cloud, Software as a Service (SaaS), and legacy systems.
Redefining Identity and Access Management
Imprivata and Verosint are working together to redefine identity and access management, creating a secure, intelligent, and unified platform tailored for modern digital healthcare enterprises. Personalized access experiences for shared devices are part of their strategy to optimize productivity for frontline and mobile workers.
This acquisition marks a significant step for Imprivata as it continues to lead in secure access management, providing organizations with innovative solutions that not only strengthen security but also enhance operational efficiency. The strategic investment aligns with the growing need for robust identity management solutions in an increasingly digital healthcare landscape.
